Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Treace Medical Concepts, Inc. (TMCI:NASDAQ), powered by AI.
Treace Medical Concepts, Inc. is currently trading at $4.12. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Treace Medical Concepts, Inc. on Alpha Lenz.
View Treace Medical Concepts, Inc.'s valuation metrics on Alpha Lenz.
“Treace Medical Concepts, Inc.'s ROE is -58.9%. Explore profitability and growth together.”
Ask for details →Treace Medical Concepts Inc. specializes in medical device development, focusing primarily on orthopedic solutions. Its flagship product is the Lapiplasty 3D Bunion Correction System, designed to address common deformities associated with bunions. This innovative system allows for precise correction in three dimensions, providing a unique, cutting-edge solution in the podiatric surgery field. Targeting hospitals, surgeons, and healthcare providers, Treace Medical Concepts plays a significant role in the medical sector by offering improved patient outcomes and recovery experiences. Headquartered in Ponte Vedra, Florida, the company supports its distribution through a strong network of sales representatives and medical partnerships in the United States. By integrating research and technology into its product design, Treace Medical Concepts Inc. contributes to advancements in surgical techniques, positioning itself as a pivotal player within the healthcare and medical device industry.
“Treace Medical Concepts, Inc.'s ROE is -58.9%. Explore profitability and growth together.”
Ask for details →Treace Medical Concepts, Inc. (ticker: TMCI) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 477 employees.
The current price is $4.12 with a P/E ratio of -x and P/B of -x.
ROE is -58.94% and operating margin is -25.46%. Annual revenue is $213M.